Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · IEX Real-Time Price · USD
8.06
+0.14 (1.77%)
Apr 22, 2024, 4:00 PM EDT - Market closed
Ironwood Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 92.15 | 657.45 | 621.38 | 364.3 | 178.27 | 174.42 | 125.74 | 62.25 | 270.03 | 82.44 | Upgrade
|
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 95.68 | 251.21 | 178.11 | 174.04 | Upgrade
|
Cash & Cash Equivalents | 92.15 | 657.45 | 621.38 | 364.3 | 178.27 | 174.42 | 221.42 | 313.46 | 448.14 | 256.48 | Upgrade
|
Cash Growth | -85.98% | 5.81% | 70.57% | 104.35% | 2.21% | -21.22% | -29.36% | -30.05% | 74.73% | 24.66% | Upgrade
|
Receivables | 129.12 | 130.05 | 138.04 | 145.75 | 149.84 | 80.95 | 82.16 | 64.85 | 54.52 | 25.84 | Upgrade
|
Inventory | 0 | 0 | 0 | 0 | 0.65 | 0 | 0.74 | 1.08 | 0 | 4.95 | Upgrade
|
Other Current Assets | 12.01 | -6.87 | -14.19 | -14.21 | -21.91 | 11.06 | 7.29 | 0.78 | -2.45 | 1.03 | Upgrade
|
Total Current Assets | 233.29 | 780.63 | 745.23 | 495.84 | 306.85 | 266.44 | 311.6 | 380.18 | 500.21 | 288.31 | Upgrade
|
Property, Plant & Equipment | 18.17 | 20.31 | 22.93 | 25.51 | 30.17 | 7.65 | 17.27 | 20.51 | 21.08 | 29.83 | Upgrade
|
Long-Term Investments | 0 | 0.49 | 0.49 | 0.49 | 0.97 | 6.43 | 7.06 | 0 | 0 | 0 | Upgrade
|
Goodwill and Intangibles | 3.68 | 0 | 0 | 0 | 0 | 0.79 | 160.69 | 166.9 | 0 | 0 | Upgrade
|
Other Long-Term Assets | 215.93 | 299.1 | 358.29 | 37.41 | 64.75 | 50.75 | 109.06 | 142.22 | 97.84 | 11.19 | Upgrade
|
Total Long-Term Assets | 237.79 | 319.89 | 381.7 | 63.4 | 95.9 | 65.62 | 294.08 | 329.64 | 118.92 | 41.02 | Upgrade
|
Total Assets | 471.07 | 1,101 | 1,127 | 559.24 | 402.75 | 332.05 | 605.67 | 709.82 | 619.12 | 329.32 | Upgrade
|
Accounts Payable | 7.83 | 0.48 | 0.94 | 0.66 | 5.49 | 14.89 | 15.96 | 17.7 | 8.59 | 9.76 | Upgrade
|
Deferred Revenue | 0 | 0 | 0 | 0 | 0.88 | 0 | 0 | 0 | 8.99 | 16.18 | Upgrade
|
Current Debt | 202.69 | 3.08 | 121.3 | 3.13 | 1.15 | 47.63 | 4.08 | 6.23 | 27.6 | 12.41 | Upgrade
|
Other Current Liabilities | 65.59 | 21.96 | 39.46 | 28.38 | 33.42 | 57.01 | 45.99 | 67.2 | 31.29 | 22.19 | Upgrade
|
Total Current Liabilities | 276.1 | 25.53 | 161.7 | 32.17 | 40.93 | 119.52 | 66.03 | 91.13 | 76.47 | 60.54 | Upgrade
|
Long-Term Debt | 512.85 | 412.85 | 355.82 | 462.66 | 454.34 | 400.06 | 488.28 | 479.81 | 429.22 | 160.72 | Upgrade
|
Other Long-Term Liabilities | 28.42 | 9.77 | 3.5 | 1.76 | 0.73 | 8.84 | 41.52 | 72.16 | 18.31 | 19.51 | Upgrade
|
Total Long-Term Liabilities | 541.27 | 422.62 | 359.32 | 464.43 | 455.07 | 408.9 | 529.8 | 551.97 | 447.53 | 180.23 | Upgrade
|
Total Liabilities | 817.37 | 448.14 | 521.02 | 496.6 | 496 | 528.42 | 595.83 | 643.11 | 524 | 240.77 | Upgrade
|
Total Debt | 715.54 | 415.93 | 477.12 | 465.79 | 455.48 | 447.69 | 492.36 | 486.04 | 456.81 | 173.13 | Upgrade
|
Debt Growth | 72.03% | -12.82% | 2.43% | 2.26% | 1.74% | -9.07% | 1.30% | 6.40% | 163.86% | -3.25% | Upgrade
|
Retained Earnings | -1,698.62 | -696.38 | -937.61 | -1,466.06 | -1,572.23 | -1,591.13 | -1,308.76 | -1,191.82 | -1,110.12 | -967.45 | Upgrade
|
Comprehensive Income | -3.03 | 0 | 0 | 0 | 0 | 0 | -0.08 | -0.01 | -0.09 | -0.02 | Upgrade
|
Shareholders' Equity | -346.3 | 652.38 | 605.91 | 62.64 | -93.25 | -196.37 | 9.85 | 66.72 | 95.13 | 88.55 | Upgrade
|
Net Cash / Debt | -623.38 | 241.52 | 144.26 | -101.49 | -277.21 | -273.26 | -270.94 | -172.58 | -8.67 | 83.35 | Upgrade
|
Net Cash / Debt Growth | - | 67.42% | - | - | - | - | - | - | - | 210.97% | Upgrade
|
Net Cash Per Share | -4.01 | 1.30 | 0.88 | -0.63 | -1.78 | -1.79 | -1.82 | -1.19 | -0.06 | 0.61 | Upgrade
|
Working Capital | -42.81 | 755.1 | 583.53 | 463.67 | 265.92 | 146.91 | 245.57 | 289.05 | 423.74 | 227.77 | Upgrade
|
Book Value Per Share | -2.23 | 4.23 | 3.73 | 0.39 | -0.60 | -1.29 | 0.07 | 0.46 | 0.67 | 0.65 | Upgrade
|